Geneva, June 20 -- International Clinical Trials Registry received information related to the study (NCT06665035) titled 'A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers' on Oct. 29, 2024.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Prevention. Masking: Double (Participant, Investigator).
Primary Sponsor: Takeda
Condition:
Dengue Fever
Intervention:
Biological: TDV
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: May 8, 2025
Target Sample Size: 212
Countries of Recruitment:
Colombia
Thailand
Colombia
Thailand
To know more, visit https://clinicaltrials.gov/ct2/show/NCT06665035
Publish...